Kybella, a deoxycholic acid injection used to improve the appearance of moderate to severe convexity or fullness, commonly referred to as "double chin," is supplied by Allergan Aesthetics, an AbbVie company [1].
Who Manufactures Kybella?
Kybella is manufactured by Allergan Aesthetics, which is part of AbbVie [1].
Where Can I Buy Kybella?
Kybella is available through licensed healthcare providers, such as dermatologists and plastic surgeons. It is administered in a clinical setting by a trained medical professional [1]. It is not available for direct purchase by consumers.
How Does Kybella Work?
Kybella contains deoxycholic acid, a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into the fat beneath the chin, deoxycholic acid destroys fat cells. Once destroyed, these cells cannot store or accumulate fat [1].
What Are the Potential Side Effects of Kybella?
Common side effects of Kybella treatment include swelling, bruising, pain, numbness, redness, and areas of hardness in the treatment area [1]. Most of these side effects are temporary and resolve on their own [1].
How Many Kybella Treatments Are Needed?
The number of Kybella treatments needed varies by individual. Many patients require an average of two to four treatments, spaced at least one month apart, to achieve their desired results. Up to six treatments may be administered [1].
When Does Kybella Patent Expiration Occur?
Information regarding specific patent expiration dates for Kybella is not readily available without specialized database access. DrugPatentWatch.com tracks patent information for pharmaceutical products, which can include details on expiration and exclusivity [2].